CoChat

New complexities in helper T cell fate determination and the implications for autoimmune diseases

Open access
Takatori, Hiroaki, Kanno, Yuka, Chen, Zhi, O’Shea, John J. · 2008 · Modern Rheumatology
Cited by 55

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Recently, new complexities in cell fate decision for helper T cells have emerged. One new lineage, which has come to be called Th17 cells, selectively produces proinflammatory cytokines including interleukin-17 (IL-17, A and F), IL-21, and IL-22. In conjunction with transforming growth factor beta-1 (TGFbeta-1), IL-6, IL-21, and IL-23, which activate the transcription factor, signal transducer, and activator of transcription 3 (Stat3), the expression of another transcription factor, retinoic acid-related orphan receptor-gammat (RORgammat) leads to the differentiation of Th17 cells in mice. Other cytokines including IL-2, IL-4, interferon-gamma (IFN-gamma), and IL-27 inhibit Th17 differentiation. However, IL-2 acting with TGFbeta-1 induces differentiation of naïve CD4+ T cells to become regulatory T cells (Tregs). Th17 cells are now known to play an important role not only in the pathogenesis of inflammation and autoimmune diseases, but also host defense against extracellular bacteria. Conversely, extensive data substantiate the role of Tregs as essential in maintenance of peripheral tolerance. Selectively targeting Tregs and Th17 cells are likely to be important strategies in the treatment of inflammatory and autoimmune diseases in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10165-008-0099-z

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 54

  1. Murphy KM, 2002, Nat Rev Immunol, 2, 933, 10.1038/nri954 · DOI · Paper page
  2. Szabo SJ, 2003, Annu Rev Immunol, 21, 713, 10.1146/annurev.immunol.21.120601.140942 · DOI · Paper page
  3. Shevach EM, 2000, Annu Rev Immunol, 18, 423, 10.1146/annurev.immunol.18.1.423 · DOI · Paper page
  4. Sakaguchi S, 2004, Annu Rev Immunol, 22, 531, 10.1146/annurev.immunol.21.120601.141122 · DOI · Paper page
  5. Kolls JK, 2004, Immunity, 21, 467, 10.1016/j.immuni.2004.08.018 · DOI · Paper page
  6. Ivanov II, 2006, Cell, 126, 1121, 10.1016/j.cell.2006.07.035 · DOI · Paper page
  7. Paul WE, 1994, Cell, 76, 241, 10.1016/0092-8674(94)90332-8 · DOI · Paper page
  8. Remmers EF, 2007, N Engl J Med, 357, 977, 10.1056/NEJMoa073003 · DOI · Paper page
  9. Ferber IA, 1996, Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol, 156, 5
  10. Mannon PJ, 2004, N Engl J Med, 351, 2069, 10.1056/NEJMoa033402 · DOI · Paper page
  11. Krueger GG, 2007, N Engl J Med, 356, 580, 10.1056/NEJMoa062382 · DOI · Paper page
  12. Oppmann B, 2000, Immunity, 13, 715, 10.1016/S1074-7613(00)00070-4 · DOI · Paper page
  13. Parham C, 2002, J Immunol, 168, 5699, 10.4049/jimmunol.168.11.5699 · DOI · Paper page
  14. Belladonna ML, 2002, J Immunol, 168, 5448, 10.4049/jimmunol.168.11.5448 · DOI · Paper page
  15. Cua DJ, 2003, Nature, 421, 744, 10.1038/nature01355 · DOI · Paper page
  16. Yen D, 2006, J Clin Invest, 116, 1310, 10.1172/JCI21404 · DOI · Paper page
  17. Lee E, 2004, J Exp Med, 199, 125, 10.1084/jem.20030451 · DOI · Paper page
  18. Michel ML, 2007, 1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med, 204, 995
  19. Langrish CL, 2005, J Exp Med, 201, 233, 10.1084/jem.20041257 · DOI · Paper page
  20. Park H, 2005, Nat Immunol, 6, 1133, 10.1038/ni1261 · DOI · Paper page
  21. Harrington LE, 2005, Nat Immunol, 6, 1123, 10.1038/ni1254 · DOI · Paper page
  22. Bettelli E, 2006, Nature, 441, 235, 10.1038/nature04753 · DOI · Paper page
  23. Korn T, 2007, Nature, 448, 484, 10.1038/nature05970 · DOI · Paper page
  24. Zhou L, 2007, Nat Immunol, 8, 967, 10.1038/ni1488 · DOI · Paper page
  25. Coquet JM, 2007, J Immunol, 178, 2827, 10.4049/jimmunol.178.5.2827 · DOI · Paper page
  26. Yang XO, 2007, J Biol Chem, 282, 9358, 10.1074/jbc.C600321200 · DOI · Paper page
  27. Harris TJ, 2007, J Immunol, 179, 4313, 10.4049/jimmunol.179.7.4313 · DOI · Paper page
  28. Mathur AN, 2006, Blood, 108, 1595, 10.1182/blood-2006-04-015016 · DOI · Paper page
  29. Batten M, 2006, Nat Immunol, 7, 929, 10.1038/ni1375 · DOI · Paper page
  30. Takeda A, 2003, J Immunol, 170, 4886, 10.4049/jimmunol.170.10.4886 · DOI · Paper page
  31. 'Thomton AM, Shevach EM. CD, 1998, J Exp Med, 188, 287, 10.1084/jem.188.2.287 · DOI · Paper page
  32. Kullberg MC, 2005, Eur J Immunol, 35, 2886, 10.1002/eji.200526106 · DOI · Paper page
  33. Bluestone JA, 2003, Nat Rev Immunol, 3, 253, 10.1038/nri1032 · DOI · Paper page
  34. Fontenot JD, 2005, Immunity, 22, 329, 10.1016/j.immuni.2005.01.016 · DOI · Paper page
  35. Chen W, 2003, J Exp Med, 198, 1875, 10.1084/jem.20030152 · DOI · Paper page
  36. Davidson TS, 2007, J Immunol, 178, 4022, 10.4049/jimmunol.178.7.4022 · DOI · Paper page
  37. Zhou L, 2008, Nature, 453, 236, 10.1038/nature06878 · DOI · Paper page
  38. Wilson NJ, 2007, Nat Immunol, 8, 950, 10.1038/ni1497 · DOI · Paper page
  39. Wolk K, 2002, Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol, 168
  40. Wolk K, 2006, Eur J Immunol, 36, 1309, 10.1002/eji.200535503 · DOI · Paper page
  41. Wolk K, 2004, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007 · DOI · Paper page
  42. Zenewicz LA, 2007, Immunity, 27, 647, 10.1016/j.immuni.2007.07.023 · DOI · Paper page
  43. Kreymborg K, 2007, J Immunol, 179, 8098, 10.4049/jimmunol.179.12.8098 · DOI · Paper page
  44. 10.2353/ajpath.2008.070690 · DOI · Paper page
  45. Smith RL, 2008, J Invest Dermatol, 128, 1325, 10.1038/sj.jid.5701140 · DOI
  46. Duerr RH, 2006, Science, 314, 1461, 10.1126/science.1135245 · DOI · Paper page
  47. Nakae S, 2003, J Immunol, 171, 6173, 10.4049/jimmunol.171.11.6173 · DOI · Paper page
  48. Rohn TA, 2006, Eur J Immunol, 36, 2857, 10.1002/eji.200636658 · DOI · Paper page
  49. Kim HR, 2007, Scand J Rheumatol, 36, 259, 10.1080/03009740701286813 · DOI
  50. Miossec P, 2007, Arthritis Rheum, 56, 2111, 10.1002/art.22733 · DOI
  51. Lubberts E, 2008, IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine, 41
  52. Toh ML, 2007, Curr Opin Rheumatol, 19, 284, 10.1097/BOR.0b013e32805e87e0 · DOI · Paper page
  53. Chabaud M, 2001, Arthritis Rheum, 44, 1293, 10.1002/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T · DOI · Paper page
  54. Voulgari PV, 2008, Expert Opin Emerg Drugs, 13, 175, 10.1517/14728214.13.1.175 · DOI

Cited by

See all 55

Metadata

Authors
Takatori, H., Kanno, Y., Chen, Z., & O’Shea, J. J.
Venue
Modern Rheumatology
Published
2008-08-05
Volume
18
Issue
6
Pages
533-541
ISSN
  • 1439-7595 (ISSN-L)
  • 1439-7609
OpenAlex
W2162210152
Cited by
55
References
14
FWCI
3.39
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New complexities in helper T cell fate determination and the implications for autoimmune diseases. https://app.cochat.ai/papers/10.1007/s10165-008-0099-z
The paper
Takatori, H., Kanno, Y., Chen, Z., & O’Shea, J. J. (2008). New complexities in helper T cell fate determination and the implications for autoimmune diseases. Modern Rheumatology. https://doi.org/10.1007/s10165-008-0099-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.